Journal profile · Medicine-Epidemiology
Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia
ISSN 1684-4386 · eISSN 2686-9586 · Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy · Russian Federation
Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia: diamond open access (no APC); no APC; review about 8 weeks (community reports); 41 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia is published by Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy. By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Antibiotic Use and Resistance and Bacterial Identification and Susceptibility Testing, together about 41.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The main purpose of the academic journal "Clinical Microbiology and Antimicrobial Chemotherapy" is to cover the issues related to clinical microbiology and infectious diseases problems. CMAC is a journal for therapeutists, surgeons, clinical pharmacologists, obstetrician-gynecologists, urologists, microbiologists, dermatovenerologists, ORT specialists, infectious diseases specialists, pediatricians, epidemiologists. The journal contains original articles, guidelines and reviews. CMAC presents actual official information from the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy and Institute of Antimicrobial Chemotherapy.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Epidemiology
Editor-in-chief Corresponding MemberPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology19.7%
- Antibiotic Use and ResistanceImmunology and Microbiology15.4%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology6.3%
- Antibiotics Pharmacokinetics and EfficacyMedicine5.9%
- Pneumonia and Respiratory InfectionsMedicine5.8%
- Antimicrobial Resistance in StaphylococcusMedicine4.8%
- Antifungal resistance and susceptibilityMedicine3.9%
- Infections and bacterial resistanceBiochemistry, Genetics and Molecular Biology3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Epidemiology | Q3 | 127/173 | 26th |
| Infectious Diseases | Q4 | 283/361 | 21st |
| Pharmacology (medical) | Q4 | 222/278 | 20th |
| Microbiology (medical) | Q4 | 124/147 | 15th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1LetPub ·
- SJR 2026-06
- 0.16LetPub ·
- SNIP 2026-06
- 0.42LetPub ·
- h-index
- 17OpenAlex ·
- i10-index
- 36OpenAlex ·
- 2-year mean citedness
- 1.01OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 419 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 40 | 228 |
| 2025 | 41 | 41 | 263 |
| 2024 | 57 | 57 | 239 |
| 2023 | 55 | 55 | 175 |
| 2022 | 49 | 49 | 198 |
| 2021 | 44 | 44 | 152 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access, Plagiarism
- Open access Open Access Policy
«Clinical Microbiology and Antimicrobial Chemotherapy» is an open access journal. All articles are available immediately upon publication. Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition - it means that articles have free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the fu…
Source ↗Publisher website ·- Plagiarism Plagiarism
«Clinical microbiology and antimicrobial chemotherapy» uses russian language plagiarism detection software Antiplagiat. If plagiarism is identified, the COPE guidelines on plagiarism will be followed.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
- Country or region
- Russian Federation
- Language
- Russian
- ISSN
- 1684-4386
- Electronic ISSN
- 2686-9586
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia
How long does peer review take at Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia?
According to LetPub and DOAJ records, Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia is indexed in Scopus and DOAJ. The journal's website also lists SCIE; that list has not been checked against each database.
Is Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia open access, and what is the APC?
Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .